Do you want to read an article? Please log in or register.
Prostate Cancer Incidence, Mortality, and Survival in Switzerland
Genitourinary Cancer
Related content
Genitourinary Cancer
Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Eur Urol
Nguyen DD, Tadayon Najafabadi B, Lin L, Kwong JCC, Miller E, Zlotta AR, Fleshner NE, Hird AE, Lofters AK, Wallis CJD, Rosella LC, Dahm P, Guyatt G, Kulkarni GS
doi: 10.1016/j.eururo.2026.04.005
Genitourinary Cancer
Survival trend in metastatic prostate cancer two decades of real-world data on overall survival from Germany
Prostate Cancer Prostatic Dis
Sondermann M, Stehr A, Hirtsiefer C, Menzel V, Buttmann-Schweiger N, Flemming PW, Kraywinkel K, Thomas C, Boehm K
doi: 10.1038/s41391-026-01092-w
Genitourinary Cancer
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate Cancer
Prostate
Falkenbach F, Di Bello F, Peñaranda NR, Longoni M, Marmiroli A, Le QC, Tian Z, Goyal JA, Longo N, Micali S, Briganti A, De Cobelli O, Chun FKH, Saad F, Shariat SF, Budäus L, Graefen M, Karakiewicz PI
doi: 10.1002/pros.70045
Genitourinary CancerFurther Publications
Radiological progression-free survival as a surrogate for overall survival in patients with metastatic hormone-sensitive prostate cancer: A bivariate meta-analysis
Eur J Cancer
Shore N, Morgans AK, Boegemann M, Gallagher E, Paracha N, Serafini P, Pushkarna D, Pourrahmat MM, Kurt M, Abrams KR
doi: 10.1016/j.ejca.2025.115513
Genitourinary Cancer
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials
Lancet Oncol
Kayani M, Murphy L, Dutey-Magni P, Howlett S, Sachdeva A, Padden-Modi M, Abdel-Aty H, Brown LC, Amos CL, Chan K, Gilbert DC, Langley RE, Brown M, Sydes MR, Parker CC, STAMPEDE Collaborators, Cross W, Malik Z, Varughese M, Turco F, Millman R, Matheson D, Gillessen S, Clarke NW, Parmar MKB, James ND, Attard G
doi: 10.1016/S1470-2045(26)00066-5
Genitourinary Cancer
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry
Eur Urol
Karpinski MJ, Hoberück S, Fendler WP, Civan C, Bundschuh RA, Thomas C, Bjartell A, Trägårdh E, Soeterik TFW, Evangelista L, Vondrak A, Rasul S, Forner L, Giorgio AD, Scholtissek H, Miksch J, Holzgreve A, Lanfranchi F, Rahbar K, Hofman MS, Rauscher I, Güven O, Eiber M, Ayati N, Umutlu L, Herrmann K, Hadaschik B, Emmett L
doi: 10.1016/j.eururo.2025.10.013
RECOMMENDED
Gastrointestinal Cancer
Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Eur J Cancer
Fournier E, Schaffar R, Staehelin K, Rouxel N, Ris F, Toso C, Frossard JL, Rapiti E, Koessler T, Wildisen L, Meyer J
doi: 10.1016/j.ejca.2026.116707
Genitourinary Cancer
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial
Ann Oncol
Tripathi A, Chen Y, Jarrard DF, Garcia JA, Dreicer R, Liu G, Hussain MH, Shevrin DH, Cooney MM, Eisenberger MA, Kohli M, Plimack ER, Vogelzang NJ, Picus J, Carducci MA, DiPaola RS, Sweeney CJ
doi: 10.1016/j.annonc.2025.08.004
Genitourinary Cancer
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer
N Engl J Med
Shore ND, Luz MA, De Giorgi U, Gleave M, Gotto GT, Pieczonka CM, Haas GP, Kim CS, Ramirez-Backhaus M, Rannikko A, Kalac M, Sridharan S, Rosales M, Tang Y, Tutrone RF Jr, Venugopal B, Villers A, Woo HH, Wang F, Freedland SJ
doi: 10.1056/NEJMoa2510310